BiPER Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Strasbourg
Industry:BiotechHealth services
Business model:B2B
BiPER Therapeutics is a preclinical biotechnology company from France developing first-in-class drug candidates targeting BiP protein to treat gastrointestinal cancers,
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 1.71M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to BiPER Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Aquilón CyL
47%
|
|
![]() |
Celluminova
47%
|
|
![]() |
Cornea Project
47%
|
|
![]() |
Ikan Biotech
47%
|
|
![]() |
In Singulo Solutions AB
47%
|
|
![]() |
Merozyne Therapeutics
47%
|
|
![]() |
PeptiSystems
47%
|
|
![]() |
Polimerbio
47%
|
|
![]() |
Sooma Medical
47%
|
|
![]() |
Synartro
47%
|
|